Last reviewed · How we verify

NCT04109911

Effect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia Adults

Completed NA Last updated 26 April 2022
What this trial tests

NA trial testing Fermented oyster extract in Muscular Sarcoidosis in 54 participants. Completed in 31 December 2020.

Timeline
25 September 2019
Primary endpoint
4 May 2020
31 December 2020

Quick facts

Lead sponsorPusan National University Yangsan Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment54
Start date25 September 2019
Primary completion4 May 2020
Estimated completion31 December 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Pusan National University Yangsan Hospital

Who can join

50 and older, any sex, with Muscular Sarcoidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the fermented oyster extract on muscle strength, muscle mass, and muscle function in healthy adults for 12 weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of fermented oyster (<i>Crassostrea gigas</i>) extracts and regular walking on muscle strength and mass in older adults with relatively low muscle mass: A randomized controlled trial.
    Lee YL, Lee SY. · · 2022 · cited 3× · PMID 35958254 · DOI 10.3389/fnut.2022.935395

Verify or expand the search:

Other Pusan National University Yangsan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04109911.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing